SCHEMBL19204573

SCHEMBL19204573

Oc1cccc(SCc2ccccn2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.51
RAB9A P51151 8/20 0.51
SMN1; SMN2 Q16637 8/20 0.51
MAPT P10636 8/20 0.51
KDM4E B2RXH2 3/20 0.51
DAO P14920 1/20 0.49
GRM5 P41594 1/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2E1 P05181 1/20 0.47
CYP2C8 P10632 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2B6 P20813 1/20 0.47
CYP2C19 P33261 1/20 0.47
LMNA P02545 1/20 0.45
HTT P42858 1/20 0.45
ALDH1A1 P00352 5/20 0.44
PKM P14618 1/20 0.44
TSHR P16473 2/20 0.44
PDE7A Q13946 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23691408 0.82 NPC1 (0.60) NPC1RAB9ASMN1; SMN2MAPTKDM4E
Hydrochloric Acid SCHEMBL10564648 0.80 NPC1 (0.58) NPC1RAB9ASMN1; SMN2MAPTKDM4E
SCHEMBL9756642 0.79 NPC1 (0.49) NPC1RAB9ASMN1; SMN2MAPTKDM4E
SCHEMBL6639465 0.77 NPC1 (0.50) NPC1RAB9ASMN1; SMN2MAPTKDM4E
Hydrochloric Acid SCHEMBL10562883 0.74 SMN1; SMN2 (0.52) NPC1RAB9ASMN1; SMN2MAPTKDM4E
SCHEMBL9656225 0.72 DAO (0.55) NPC1RAB9ASMN1; SMN2MAPTKDM4E
SCHEMBL6639863 0.72 NPC1 (0.61) NPC1RAB9ASMN1; SMN2MAPTKDM4E
SCHEMBL9376353 0.72 NPC1 (0.57) NPC1RAB9ASMN1; SMN2MAPTKDM4E
SCHEMBL21623739 0.72 NPC1 (0.47) NPC1RAB9ASMN1; SMN2MAPTKDM4E
Hydrochloric Acid SCHEMBL9695063 0.71 NPC1 (0.56) NPC1RAB9ASMN1; SMN2MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963433-B2 Anticancer drugs including the chemical structures of an androgen receptor ligand and a histone deacetylase inhibitor WAYNE STATE UNIVERSITY (US) 2018-05-08 US disclosed
US-20170217903-A1 ANTICANCER DRUGS INCLUDING THE CHEMICAL STRUCTURES OF AN ANDROGEN RECEPTOR LIGAND AND A HISTONE DEACETYLASE INHIBITOR WAYNE STATE UNIVERSITY 2017-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170217903-A1 ANTICANCER DRUGS INCLUDING THE CHEMICAL STRUCTURES OF AN ANDROGEN RECEPTOR LIGAND AND A HISTONE DEACETYLASE INHIBITOR AR, HDAC1, HDAC11 NPC1 2397/4885RAB9A 3862/4885SMN1; SMN2 4835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.